NCT05879302

Brief Summary

The goal of this pilot randomized trial is to learn about shared decision making in kidney transplant candidates. The aim of this proposal is to evaluate the Donor Plan Donor Choice tool to promote high-quality Shared Decision Making for providers and kidney transplant candidates at two transplant centers. Participants will:

  • Review an online education tool, Donor Plan Donor Choice.
  • Discuss a Kidney Offer Plan with a transplant provider.
  • Answer questions about willingness to consider different donor types. Researchers will compare the Shared Decision Making group to usual care to generate pilot data and implementation outcomes for a larger trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

April 3, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 17, 2026

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1.9 years

First QC Date

May 17, 2023

Last Update Submit

April 8, 2026

Conditions

Keywords

Shared Decision MakingSDMTransplantationOrgan offerKidney offerKDPI

Outcome Measures

Primary Outcomes (1)

  • Willingness to accept donor organs at risk of discard

    Willingness to accept a donor kidney offer will be measured by three items on a 5-point Likert scale anchored by "strongly agree" and "strongly disagree." Willingness to accept will be defined by answers of "agree" or "strongly agree."

    Up to 2 months

Secondary Outcomes (4)

  • Knowledge

    Up to 2 months

  • Decisional Conflict

    Up to 2 months

  • Distress

    Up to 2 months

  • Shared Decision Making

    Up to 2 months

Study Arms (2)

Shared Decision Making Intervention

EXPERIMENTAL

Receives the Shared Decision Making Intervention

Behavioral: Kidney Offer Shared Decision Making

Usual Care

NO INTERVENTION

Receives Usual Care, eg. usual patient education and counseling for kidney transplant candidates.

Interventions

The intervention consists of receiving the Donor Offer Plan (DOP), reviewing a web-based educational module about donor offers including practice offer videos, followed by a discussion about the DOP with a transplant nurse coordinator.

Shared Decision Making Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidate on the kidney transplant waiting list
  • Greater than 3 months since listing for transplant
  • Years of age or older
  • English-speaking

You may not qualify if:

  • Non-English speaking
  • \< 18 years of age
  • Patients who choose to opt out of research.
  • Unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hennepin Healthcare

Minneapolis, Minnesota, 55415, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All study personnel involved in screening and enrollment will be masked to upcoming randomization assignments
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

May 17, 2023

First Posted

May 30, 2023

Study Start

April 3, 2024

Primary Completion

February 17, 2026

Study Completion

February 17, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations